These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16579822)

  • 1. Strengthening the case for disease management effectiveness: un-hiding the hidden bias.
    Linden A; Adams JL; Roberts N
    J Eval Clin Pract; 2006 Apr; 12(2):140-7. PubMed ID: 16579822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITT for observational data: worst of both worlds?
    Stampfer MJ
    Epidemiology; 2008 Nov; 19(6):783-4; discussion 789-93. PubMed ID: 18813017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving participant selection in disease management programmes: insights gained from propensity score stratification.
    Linden A; Adams JL
    J Eval Clin Pract; 2008 Oct; 14(5):914-8. PubMed ID: 19018926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does analysis using "last observation carried forward" introduce bias in dementia research?
    Molnar FJ; Hutton B; Fergusson D
    CMAJ; 2008 Oct; 179(8):751-3. PubMed ID: 18838445
    [No Abstract]   [Full Text] [Related]  

  • 6. A new u-statistic with superior design sensitivity in matched observational studies.
    Rosenbaum PR
    Biometrics; 2011 Sep; 67(3):1017-27. PubMed ID: 21175557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on randomization and selection bias in maintenance therapy clinical trials.
    Greenhouse JB; Meyer MM
    Psychopharmacol Bull; 1991; 27(3):225-9. PubMed ID: 1775592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
    Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M
    Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, confounding, and the illusion of statistical control.
    Christenfeld NJ; Sloan RP; Carroll D; Greenland S
    Psychosom Med; 2004; 66(6):868-75. PubMed ID: 15564351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating disease management programme effectiveness: an introduction to the regression discontinuity design.
    Linden A; Adams JL; Roberts N
    J Eval Clin Pract; 2006 Apr; 12(2):124-31. PubMed ID: 16579820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical issues in longitudinal and observational studies: purpose, short versus long term, selection of study instruments, methods, outcomes, and biases.
    Wolfe F
    J Rheumatol; 1999 Feb; 26(2):469-72. PubMed ID: 9972989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 16. A potential bias in safety evaluation during open-label extensions of randomized clinical trials.
    Rothman KJ
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):295-8. PubMed ID: 15133780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster randomized controlled trials in primary care: an introduction.
    Murphy AW; Esterman A; Pilotto LS
    Eur J Gen Pract; 2006; 12(2):70-3. PubMed ID: 16945880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating disease management programme effectiveness: an introduction to instrumental variables.
    Linden A; Adams JL
    J Eval Clin Pract; 2006 Apr; 12(2):148-54. PubMed ID: 16579823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity analysis for matched case-control studies.
    Rosenbaum PR
    Biometrics; 1991 Mar; 47(1):87-100. PubMed ID: 2049516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.